The myotonic dystrophies: molecular, clinical, and therapeutic challenges
B Udd, R Krahe - The Lancet Neurology, 2012 - thelancet.com
Myotonic dystrophy is the most common type of muscular dystrophy in adults and is
characterised by progressive myopathy, myotonia, and multiorgan involvement. Two …
characterised by progressive myopathy, myotonia, and multiorgan involvement. Two …
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
B Udd, R Krahe - The Lancet Neurology, 2012 - Elsevier
Myotonic dystrophy is the most common type of muscular dystrophy in adults and is
characterised by progressive myopathy, myotonia, and multiorgan involvement. Two …
characterised by progressive myopathy, myotonia, and multiorgan involvement. Two …
[引用][C] The myotonic dystrophies: molecular, clinical, and therapeutic challenges
B Udd, R Krahe - The Lancet Neurology, 2012 - cir.nii.ac.jp
[PDF][PDF] The myotonic dystrophies: molecular, clinical, and therapeutic challenges
B Udd, R Krahe - Lancet Neurol, 2012 - researchgate.net
RNA-binding proteins, resulting in a spliceopathy of downstream effector genes. The
prevailing paradigm therefore is that both disorders are toxic RNA diseases. However …
prevailing paradigm therefore is that both disorders are toxic RNA diseases. However …
The myotonic dystrophies: Molecular, clinical, and therapeutic challenges
B Udd, R Krahe - The Lancet Neurology, 2012 - mdanderson.elsevierpure.com
Myotonic dystrophy is the most common type of muscular dystrophy in adults and is
characterised by progressive myopathy, myotonia, and multiorgan involvement. Two …
characterised by progressive myopathy, myotonia, and multiorgan involvement. Two …
The myotonic dystrophies: molecular, clinical, and therapeutic challenges.
B Udd, R Krahe - The Lancet. Neurology, 2012 - europepmc.org
Myotonic dystrophy is the most common type of muscular dystrophy in adults and is
characterised by progressive myopathy, myotonia, and multiorgan involvement. Two …
characterised by progressive myopathy, myotonia, and multiorgan involvement. Two …
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
B Udd, R Krahe - The Lancet Neurology, 2012 - infona.pl
Myotonic dystrophy is the most common type of muscular dystrophy in adults and is
characterised by progressive myopathy, myotonia, and multiorgan involvement. Two …
characterised by progressive myopathy, myotonia, and multiorgan involvement. Two …
[引用][C] The myotonic dystrophies: molecular, clinical, and therapeutic challenges
B Udd, R Krahe - The Lancet Neurology, 2012 - researchportal.tuni.fi
The myotonic dystrophies: molecular, clinical, and therapeutic challenges — Tampere University
Research Portal Skip to main navigation Skip to search Skip to main content Tampere University …
Research Portal Skip to main navigation Skip to search Skip to main content Tampere University …
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
B Udd, R Krahe - Lancet Neurol, 2012 - thelancet.com
RNA-binding proteins, resulting in a spliceopathy of downstream effector genes. The
prevailing paradigm therefore is that both disorders are toxic RNA diseases. However …
prevailing paradigm therefore is that both disorders are toxic RNA diseases. However …
[PDF][PDF] The myotonic dystrophies: molecular, clinical, and therapeutic challenges
B Udd, R Krahe - Lancet Neurol, 2012 - academia.edu
RNA-binding proteins, resulting in a spliceopathy of downstream e ector genes. The
prevailing paradigm therefore is that both disorders are toxic RNA diseases. However …
prevailing paradigm therefore is that both disorders are toxic RNA diseases. However …